FDA approves first oral PCSK9 inhibitor pill to lower LDL cholesterol

The FDA has approved the first oral PCSK9 inhibitor pill to lower LDL cholesterol in adults with high cholesterol. Until now, all PCSK9 inhibitors were available only as injectable drugs. The approval marks a significant expansion of treatment options for patients at cardiovascular risk.